Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug
Pharmaceutical Business Review
Mon, 05/11/20 - 10:27 am
AstraZeneca
Daiichi Sankyo
FDA
Enhertu
gastric cancer
breakthrough therapy
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
Motley Fool
Thu, 05/7/20 - 10:46 am
FDA
drug approvals
Gilead Sciences
remdesivir
AstraZeneca
Merck
Lynparza
Clovis Oncology
Rubraca
Bristol-Myers Squibb
Opdivo
Yervoy
Go or no go? Oncology dominates upcoming decisions
EP Vantage
Fri, 05/1/20 - 11:09 am
FDA
oncology
AstraZeneca
Lynparza
ovarian cancer
prostate cancer
Bristol-Myers Squibb
Opdivo
lung cancer
AstraZeneca, racing past rivals, throws its weight behind Oxford's COVID-19 vaccine
BioPharma Dive
Thu, 04/30/20 - 10:51 am
AstraZeneca
vaccines
University of Oxford
COVID-19
pandemic
AZ maintains 2020 guidance as Q1 sales grow despite pandemic
Pharmaforum
Wed, 04/29/20 - 10:49 am
AstraZeneca
earnings
COVID-19
pandemic
Positive Prostate Cancer Results for Lynparza Are Bad News for Clovis Oncology
Motley Fool
Mon, 04/27/20 - 07:27 pm
Clovis Oncology
Rubraca
AstraZeneca
Merck
Lynparza
prostate cancer
AstraZeneca and Merck's Lynparza Improves Survival in Prostate Cancer with Specific Repair Gene Mutations
BioSpace
Sat, 04/25/20 - 12:10 am
AstraZeneca
Merck
clinical trials
Lynparza
metastatic castration-resistant prostate cancer
prostate cancer
To Help High-Risk COVID-19 Patients, AstraZeneca's Testing a Diabetes Treatment
Motley Fool
Thu, 04/23/20 - 09:09 pm
AstraZeneca
diabetes
Farxiga
COVID-19
British government enlists AstraZeneca, BIA for new pandemic vaccine taskforce
Fierce Biotech
Sun, 04/19/20 - 11:08 pm
COVID-19
UK
vaccines
drug development
AstraZeneca
Pascal Soriot, lamenter of low pay, faces investor revolt for being overcompensated
Endpoints
Thu, 04/16/20 - 10:57 am
AstraZeneca
Pascal Soriot
executive pay
Pharma CEOs
AZ, Lilly join efforts to develop drugs for COVID-19
Pharmaforum
Tue, 04/14/20 - 09:50 am
AstraZeneca
Eli Lilly
COVID-19
olumiant
Calquence
EXCLUSIVE: AstraZeneca’s Calquence Shows Early Promise For COVID-19 Patients
Forbes
Mon, 04/13/20 - 09:35 pm
AstraZeneca
clinical trials
Calquence
AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy
Endpoints
Mon, 04/13/20 - 11:06 am
AstraZeneca
Tagrisso
clinical trials
non-small cell lung cancer
AstraZeneca, Merck secure FDA nod for Koselugo to treat paediatric patients with NF1 genetic disorder
Pharmaceutical Business Review
Mon, 04/13/20 - 10:46 am
AstraZeneca
Merck
FDA
Koselugo
pediatric
neurofibromatosis
A bruised Circassia offloads debt by returning COPD drugs to AstraZeneca
Endpoints
Thu, 04/9/20 - 10:37 am
Circassia
AstraZeneca
COPD
AstraZeneca targets summer start for COVID-19 antibody trial
Fierce Biotech
Wed, 04/8/20 - 10:31 am
AstraZeneca
antibodies
clinical trials
COVID-19
GSK, AstraZeneca in talks for joint U.K. COVID-19 diagnostics project: Bloomberg
Fierce Biotech
Tue, 04/7/20 - 10:40 am
GSK
AstraZeneca
UK
diagnostics
COVID-19
AstraZeneca on expanding its diabetes research franchise
Pharmaforum
Fri, 04/3/20 - 11:17 am
AstraZeneca
diabetes
AstraZeneca's Farxiga Shows 'Overwhelming Efficacy' in Phase III CKD Trial
BioSpace
Mon, 03/30/20 - 08:12 pm
AstraZeneca
chronic kidney disease
clinical trials
Farxiga
AstraZeneca's Imfinzi gets FDA nod to target small-cell lung cancer
Reuters
Mon, 03/30/20 - 10:49 am
AstraZeneca
FDA
Imfinzi
lung cancer
Small-Cell Lung Cancer
Pages
« first
‹ previous
…
43
44
45
46
47
48
49
50
51
…
next ›
last »